Jaspers S R, Miller T B
Department of Biochemistry, University of Massachusetts Medical Center, Worcester 01655.
Mol Cell Biochem. 1991 Mar 13;101(2):167-74. doi: 10.1007/BF00229533.
Protein phosphatase 2A1 was purified from rat skeletal muscle and used to produce antisera to the three subunits of the holoenzyme. Affinity purified antibodies specific for the subunits of the phosphatase enzyme were found to recognize the type 2A1 and 2A2 phosphatase from rat skeletal muscle, heart, liver, brain and erythrocytes and were used to investigate the effects of diabetes on the levels of this enzyme in liver and heart. Phosphorylase phosphatase assays coupled with immunoblot analysis of fractionated rat liver and heart cytosol from normal and diabetic animals show no apparent differences in the quantity or activity of these enzymes following the induction of alloxan diabetes. When considering these results and the normal physiological concentrations of known effectors of these enzymes, it is likely that protein phosphatase 2A1 and 2A2 are not responsible for the dephosphorylation of phosphorylase a under physiological conditions.
从大鼠骨骼肌中纯化出蛋白磷酸酶2A1,并用于制备针对全酶三个亚基的抗血清。发现对磷酸酶亚基具有特异性的亲和纯化抗体可识别来自大鼠骨骼肌、心脏、肝脏、大脑和红细胞的2A1型和2A2型磷酸酶,并用于研究糖尿病对肝脏和心脏中该酶水平的影响。对正常和糖尿病动物的大鼠肝脏和心脏细胞溶胶进行分级分离,并结合免疫印迹分析进行磷酸化酶磷酸酶测定,结果显示,在诱导四氧嘧啶糖尿病后,这些酶的数量或活性没有明显差异。考虑到这些结果以及这些酶已知效应物的正常生理浓度,蛋白磷酸酶2A1和2A2在生理条件下可能不负责磷酸化酶a的去磷酸化。